|
WDR5 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62481139653892E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
2.77790000002831E-07 |
| Normal-vs-Stage3 |
5.55111512312578E-15 |
| Normal-vs-Stage4 |
1.63802305053196E-12 |
| Stage1-vs-Stage2 |
2.148600E-01 |
| Stage1-vs-Stage3 |
6.726800E-01 |
| Stage1-vs-Stage4 |
1.158840E-01 |
| Stage2-vs-Stage3 |
1.456790E-01 |
| Stage2-vs-Stage4 |
4.107600E-02 |
| Stage3-vs-Stage4 |
3.052000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
1.69349999579183E-08 |
| Normal-vs-Asian |
1.67090008496018E-10 |
| Caucasian-vs-AfricanAmerican |
8.259400E-01 |
| Caucasian-vs-Asian |
2.913200E-01 |
| AfricanAmerican-vs-Asian |
3.639200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.38729044813135E-13 |
| Normal-vs-Female |
1.6242562850266E-12 |
| Male-vs-Female |
5.088200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(41-60Yrs) |
2.77555756156289E-15 |
| Normal-vs-Age(61-80Yrs) |
1.62625468647093E-12 |
| Normal-vs-Age(81-100Yrs) |
6.28529999999738E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.260000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.231200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.999800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.773600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.525000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.590000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.558300E-02 |
| Classical-VS-Follicular |
6.112200E-01 |
| Classical-VS-Other |
5.369400E-01 |
| Classical-VS-Normal |
1.62458935193399E-12 |
| Tall-VS-Follicular |
1.272570E-01 |
| Tall-VS-Other |
6.754200E-01 |
| Tall-VS-Normal |
2.82485146385625E-12 |
| Follicular-VS-Other |
7.461200E-01 |
| Follicular-VS-Normal |
9.02822261394931E-12 |
| Other-VS-Normal |
1.983690E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.88737914186277E-15 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
9.976400E-04 |
|
|
